UNSPSC 85611913: Occlusion of cystic duct, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of cystic duct, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FL87ZZ

UNSPSC 85611913 Occlusion of cystic duct, via natural or artificial opening is a Commodity code that does not align with the state and local procurement opportunities recently posted under this taxonomy. The code nominally describes a specific surgical procedure — occlusion or closure of the cystic duct through endoscopic or minimally invasive means — yet the recent opportunities tagged with this code involve occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, independent medical evaluations for pension disability determinations, surgical benefit carve-out programs, and emergency medical services for youth in custody. None of these solicitations concern the procurement of cystic duct occlusion procedures, endoscopic supplies, or related surgical services. The mismatch indicates either systematic miscoding by issuing bodies or that this code is being applied as a default catchall for health services unrelated to the procedure it nominally describes.

The opportunities originating from the Washington State Department of Transportation (occupational medical surveillance for ferry workers), City of Phoenix Retirement Office (independent disability medical evaluations), City of Long Beach (surgical benefit Centers of Excellence network), Collier County (pharmacy benefit management), County of Santa Clara (temporary ancillary health professional staffing), and Harris County Juvenile Probation Department (emergency and inpatient hospital services for detained youth) represent diverse issuing bodies across multiple states and service lines. The geographic spread spans Washington, Arizona, California, Florida, and Texas, with no clear concentration. Recent response dates range from September 2026 through April 2026, though no opportunities directly procure the cystic duct occlusion service the code nominally represents. The code shows little relevant recent activity aligned with its stated scope.